A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Post founder Noam Bardin is on a mission to reinvent social media and break Big Tech’s destructive dominance
Free speech, racial equity battles play out on Wisconsin campuses
EU industry chief warns Alphabet CEO on tech rules compliance after Hamas attack
Astronauts dropped a toolbag in space which you can see with just binoculars
Snap Appoints India Head, Announces Revamp in Growth Push
AI boss says 'heavy regulation' now could block progress
More than half of Americans have experienced online hate and harassment, report finds
Justin Trudeau blasts Facebook for blocking news as Canada's wildfires rage